Three vaccines have entered phase two of clinical trials in China, and more research is needed to evaluate their safety and efficacy. AsiaNewsNetwork
BEIJING — Three vaccines – one adenovirus vector and two inactivated – have entered phase two of clinical trials in China, and more research is needed to evaluate their safety and efficacy, a researcher said on Monday.
Wang Guiqiang, director of infectious diseases at Peking University’s First Hospital, said that China has five types of vaccines in development, and they are progressing smoothly.The vector vaccine is spearheaded by senior preventive medicine expert Chen Wei. One inactivated vaccine is created by the Wuhan Institute of Biological Products Co Ltd, and the other is by Sinovac Research and Development Co Ltd, he said at a news briefing.
Wang said that China is also testing convalescent plasma transfusion, stem cell therapy, and monoclonal antibodies to treat COVID-19. Around 600 to 700 patients have received plasma transfusions and seen their symptoms improve.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Beijing using COVID-19 aid to prevent criticism in S. China Sea aggression: analyst
Read more »
Three-day draft viewership breaks records, NFL says
Read more »
Three Beijing activists missing after preserving virus articles online
Read more »
Back to school in China as lockdowns start to ease worldwideLeaders and experts around the world remain divided on how quickly to revive shuttered economies while maintaining a delicate balance between freedom and safety. coronavirus
Read more »
China envoy threatens Australia boycott over virus inquest demandIn a thinly veiled threat, ambassador Cheng Jingye warns the push for an independent inquest into the origins of the outbreak was 'dangerous.' coronavirus
Read more »
China seizes over 89 million shoddy face masks
Read more »